News

Children With Absence Seizures Require Close Monitoring


 

MIAMI — Absence epilepsy seizures can be differentiated from daydreaming or ADHD with an office procedure involving nothing more than a piece of paper.

“Hyperventilate the child by having them blow on a paper or on their own, and you will see loss of consciousness [if they have absence epilepsy],” said Dr. Michael S. Duchowny. “It's a very easy thing to do in your office.”

In the absence of a piece of paper, one tip is an obvious onset and offset of the transient loss of consciousness characteristic of absence seizures. “You cannot snap the child out of it during an episode,” Dr. Duchowny said.

EEG can confirm the diagnosis of absence epilepsy. The readout will show bilateral, symmetric, and synchronous 3-Hz spikes and wave discharges against a normal EEG background, Dr. Duchowny said.

The age at which a child presents with absence seizures is an important consideration. Physicians who suspect a child is having absence seizures—which were formerly known as petit mal epilepsy—should rule out other conditions, said Dr. Duchowny, director of the comprehensive epilepsy program at Miami Children's Hospital.

Onset of absence seizures is usually at 5–12 years old. “A red flag should go up with any child who comes into your office before age 5 with absence seizures. This is unusual—you need to look for other developmental disorders,” Dr. Duchowny said at a meeting sponsored by Miami Children's Hospital.

First-line treatment includes antiepileptic drugs (AEDs) like ethosuximide, valproic acid, or clonazepam, Dr. Duchowny said. Newer AEDs are also effective, such as lamotrigine, levetiracetam, or topiramate. AEDS to avoid include carbamazepine, oxcarbazepine, phenytoin, and gabapentin. Dr. Duchowny received an honorarium from and is on the speakers bureau for GlaxoSmithKline Inc.

Despite timely treatment, children with absence epilepsy should be monitored for adverse psychosocial effects, Dr. Duchowny said. “If one looks long term at children with absence seizures, sometimes the outlook may not be as favorable as we think.”

For example, adults with a history of childhood absence seizures, even when they remained seizure-free, had greater difficulty with academic, social, and behavior domains, according to a cohort study (Arch. Pediatr. Adolesc. Med. 1997;151:152–8). The mean follow-up for the 58 patients in the study was 23 years.

Absence seizures can occur as a discrete seizure type or a robust epilepsy syndrome with associated symptoms. If the child has the syndrome, physicians and parents might see frequent automatisms, such as lip smacking or eye closure, especially during longer seizures.

“Absences tend to disappear around age 15 or 16 years,” Dr. Duchowny said. “You can tell families these seizures will not recur later in life. They 'time on' but they also 'time off.'” If the child experiences mixed seizure types, such as concomitant generalized tonic-clonic seizures, they can persist in some patients, he added.

Absence seizures must be the initial and most prominent type of seizure for the diagnosis of childhood absence epilepsy. “By and large, these children are neurologically healthy,” Dr. Duchowny said.

In contrast, a small subset of patients can have atypical absence seizures. Poor seizure control and persistence of epilepsy are more common with atypical seizures. “These typically occur in children with some type of associated neurologic disability,” Dr. Duchowny said. The seizures generally occur in children with development delay and often coexist with other seizure types, especially tonic-clonic, myoclonic, and tonic seizures. “These children often have a much poorer neurodevelopmental outcome, including less control of seizures, even with medication.”

Recommended Reading

Carisbamate Shows Antiepileptic Efficacy; Phase III Studies Planned
MDedge Neurology
Generic Substitution Boosts Total Cost of Epilepsy Care
MDedge Neurology
Data Watch: Epilepsy-Related Hospital Stays Are on the Rise
MDedge Neurology
Bipolar Symptoms, Depression Cluster in Epilepsy Patients
MDedge Neurology
Lacosamide Shows Epilepsy Efficacy in Phase III
MDedge Neurology
Drug Withdrawal Safe After a Prolonged Seizure-Free Period
MDedge Neurology
Children With Epilepsy Show Bone Deficits
MDedge Neurology
Device Promising in Uncontrolled Seizures
MDedge Neurology
Additional Data Link Valproate Use to Birth Defects
MDedge Neurology
Questionnaire Detects Depression in Epilepsy
MDedge Neurology